ArticleJournal of clinical medicine2023

Mild Cardiotoxicity and Continued Trastuzumab Treatment in the Context of HER2-Positive Breast Cancer.

Orianne de la Brassinne Bonardeaux et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.